Knightsbridge Asset Management’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Hold
29,300
– – 0.12% 98
2026
Q2
$957K Hold
29,300
– – 0.13% 88
2026
Q1
$849K Hold
29,300
– – 0.11% 93
2025
Q4
$832K Hold
29,300
– – 0.13% 78
2025
Q3
$712K Hold
29,300
– – 0.12% 82
2025
Q2
$619K Hold
29,300
– – 0.14% 80
2025
Q1
$621K Hold
29,300
– – 0.16% 74
2024
Q4
$631K Hold
29,300
– – 0.15% 81
2024
Q3
$697K Hold
29,300
– – 0.16% 71
2024
Q2
$667K Hold
29,300
– – 0.17% 66
2024
Q1
$641K Hold
29,300
– – 0.18% 68
2023
Q4
$641K Buy
+29,300
New +$577K 0.18% 68

Other funds holding IBBQ

Knightsbridge Asset Management's IBBQ Position: Q3 2026 in Review

Knightsbridge Asset Management held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q3 2026 at 29,300 shares worth $1.03M. The position accounts for 0.12% of the portfolio, ranked #98.

Knightsbridge Asset Management first reported a position in IBBQ in Q4 2023 and has held it in 12 quarters since. 45 funds tracked by Wall St. Rank hold IBBQ as of Q3 2026.

  • Knightsbridge Asset Management held 29,300 shares of Invesco NASDAQ Biotechnology ETF worth $1.03M as of Q3 2026.
  • Knightsbridge Asset Management left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q3 2026.
  • Invesco NASDAQ Biotechnology ETF made up 0.12% of Knightsbridge Asset Management's portfolio in Q3 2026, its #98 holding.
  • Knightsbridge Asset Management first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2023 and has held it in 12 quarters since.
  • 45 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2026.

Based on Knightsbridge Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.